<DOC>
	<DOCNO>NCT02359552</DOCNO>
	<brief_summary>This Phase II , randomize , double blind , placebo control , parallel group , proof concept three-site study , evaluate effect Rasagiline regional brain metabolism 18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose ( FDG-PET ) .</brief_summary>
	<brief_title>Rasagiline Rescue Alzheimer 's Disease Clinical Trial</brief_title>
	<detailed_description>The study consist two phase : 24 week double blind placebo control treatment period 4 week follow period . Patients randomize 1 : 1 ratio baseline receive either Rasagiline matching placebo The study drug give 0.5 mg dose daily 4 week , increase 1 mg daily next 20 week . A total 50 subject enrol : 25 receive Rasagiline 25 receive match placebo 24-week treatment period . Primary objective determine exposure 1 mg Rasagiline daily associate improved regional brain metabolism treatment group compare placebo group Alzheimer 's Disease patient</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>Males females 50 90 age inclusive . Diagnosis probable AD ( NINCDSADRDA criterion ) Positive fluorodeoxyglucose PET ( [ 18F ] FDG PET ) scan compatible AD determine ADM Diagnostics LLC ( ADMdx ) Criteria screen Mini Mental Status Exam = 12 22 ( inclusive ) Must study partner able willing comply require study procedure . Have least eight year education previously ( preAD condition ) capable reading , write , communicate effectively others English . If receive therapy cholinesterase inhibitor and/or memantine , dose agent stable least 3 month prior screen Any nonAD neurological disease MRI find indication nonAD diagnosis Screening laboratory study 1.5 time high low range normal test respectively History melanoma ; history malignancy within past five year exception basal cell squamous cell cancer , insitu cervical cancer , localize prostate cancer</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>